NE Journal of Medicine Backs Congressional Call for Research Transparency

By
-
0
82

Rep. Ed Markey (D-MA) introduced the Trial and Experimental Studies Transparency (TEST) Act into congress on August 2, 2012; a bill aimed at closing loopholes in the current FDA process for trial registration. The New England Journal of Medicine, in an editorial penned by Dr. Jeffrey M. Drazen, says “… clinical trials should be conducted in the open, with full public knowledge of the question asked, the intervention tested, and the results obtained. The TEST Act is another step toward this end, and we strongly support it.”

Editorial → 

Previous article“A Drop of Sunshine”
Next articleGAO Calls for Patient-Centered Research, Public Comment
Kermit Cole
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

LEAVE A REPLY